Self-assembled chitosan nanoparticles for intranasal delivery of recombinant protein interleukin-17 receptor C (IL-17RC): preparation and evaluation in asthma mice

References

• Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16(1):45–56.
   PubMed Web of Science ®Google Scholar
• Surachmanto E, Hatta M, Islam A, et al. Association between asthma control and Interleukin-17F expression levels in adult patients with atopic asthma. Saudi Med J. 2018;39:662–667.
   PubMed Web of Science ®Google Scholar
• Nakae S, Komiyama Y, Nambu A, et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity. 2002;17(3):375–387.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yang J, Gao YD, et al. Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol. 2010;151(4):297–307.
   PubMed Web of Science ®Google Scholar
• Al-Ramli W, Préfontaine D, Chouiali F, et al. TH17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol. 2009;123(5):1185–1187.
   PubMed Web of Science ®Google Scholar
• Park SJ, Lee YC. Interleukin-17 regulation: an attractive therapeutic approach for asthma. Respir Res. 2010;11(1):78.
   PubMedGoogle Scholar
• Ota K, Kawaguchi M, Matsukura S, et al. Potential involvement of IL-17F in asthma. J Immunol Res. 2014;2014:602846.
   PubMed Web of Science ®Google Scholar
• Cosmi L, Liotta F, Maggi E, et al. Th17 cells: new players in asthma pathogenesis. Allergy. 2011;66(8):989–998.
   PubMed Web of Science ®Google Scholar
• Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol. 2001;108(3):430–438.
   PubMed Web of Science ®Google Scholar
• Song X, He X, Li X, et al. The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity. Cell Mol Immunol. 2016;13(4):418–431.
   PubMed Web of Science ®Google Scholar
• Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 2009;9(8):556–567.
   PubMed Web of Science ®Google Scholar
• Pappu R, Ramirez-Carrozzi V, Sambandam A. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology. 2011;134(1):8–16.
   PubMed Web of Science ®Google Scholar
• Ho AW, Gaffen SL. IL-17RC: a partner in IL-17 signaling and beyond. Semin Immunopathol. 2010;32(1):33–42.
   PubMed Web of Science ®Google Scholar
• Kuestner RE, Taft DW, Haran A, et al. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J Immunol (Baltimore, Md: 1950). 2007;179(8):5462–5473.
   PubMed Web of Science ®Google Scholar
• Haudenschild D, Moseley T, Rose L, et al. Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer. J Biol Chem. 2002;277(6):4309–4316.
   PubMed Web of Science ®Google Scholar
• Ge D, You Z. Expression of interleukin-17RC protein in normal human tissues. Int Arch Med. 2008;1(1):19.
   PubMedGoogle Scholar
• Amidi M, Romeijn SG, Borchard G, et al. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release. 2006;111:107–116.
   PubMed Web of Science ®Google Scholar
• Turker S, Onur E, Ozer Y. Nasal route and drug delivery systems. Pharm World Sci. 2004;26(3):137–142.
   PubMedGoogle Scholar
• Davis SS. Nasal vaccines. Adv Drug Deliv Rev. 2001;51(1–3):21–42.
   PubMed Web of Science ®Google Scholar
• Zaman M, Chandrudu S, Toth I. Strategies for intranasal delivery of vaccines. Drug Deliv Transl Res. 2013;3(1):100–109.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang H, Wu Z, et al. Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles. Eur J Pharm Biopharm. 2008;68(3):526–534.
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiao Y, Wang Y, et al. Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev. 2008;60(15):1650–1662.
   PubMed Web of Science ®Google Scholar
• Csaba N, Koping-Hoggard M, Alonso MJ. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int J Pharm. 2009;382(1–2):205–214.
   PubMed Web of Science ®Google Scholar
• Grenha A, Seijo B, Remunan-Lopez C. Microencapsulated chitosan nanoparticles for lung protein delivery. Eur J Pharm Sci. 2005;25(4–5):427–437.
   PubMed Web of Science ®Google Scholar
• Fan W, Yan W, Xu Z, et al. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B Biointerfaces. 2012;90:21–27.
   PubMed Web of Science ®Google Scholar
• Lin YS, Radzi R, Morimoto M, et al. Characterization of chitosan-carboxymethyl dextran nanoparticles as a drug carrier and as a stimulator of mouse splenocytes. J Biomater Sci Polym Ed. 2012;23(11):1401–1420.
   PubMed Web of Science ®Google Scholar
• Guo S, Wu L-X, Jones C-X, et al. Allergic airway inflammation disrupts interleukin-17 mediated host defense against streptococcus pneumoniae infection. Int Immunopharmacol. 2016;31:32–38.
   PubMed Web of Science ®Google Scholar
• Xu W, Chen L, Guo S, et al. Intranasal administration of recombinant mycobacterium smegmatis inducing IL-17A autoantibody attenuates airway inflammation in a murine model of allergic asthma. PLoS One. 2016;11(3):e0151581.
   PubMed Web of Science ®Google Scholar
• De Luca A, Pariano M, Cellini B, et al. The IL-17F/IL-17RC axis promotes respiratory allergy in the proximal airways. Cell Rep. 2017;20(7):1667–1680.
   PubMed Web of Science ®Google Scholar
• Qin XJ, Zhang GS, Zhang X, et al. Protein tyrosine phosphatase SHP2 regulates TGF-β1 production in airway epithelia and asthmatic airway remodeling in mice. Allergy. 2012;67(12):1547–1556.
   PubMed Web of Science ®Google Scholar
• Du Y, Tong Y, Mei W, et al. A truncated IL-17RC peptide ameliorates synovitis and bone destruction of arthritic mice. Adv Healthc Mater. 2016;5(22):2911–2921.
   PubMed Web of Science ®Google Scholar
• Kawaguchi M, Kokubu F, Fujita J, et al. Role of Interleukin-17F in asthma. Inflammation & Allergy-Drug Targets. 2009;8(5):383–389.
   PubMedGoogle Scholar
• Gao P, Xia G, Bao Z, et al. Chitosan based nanoparticles as protein carriers for efficient oral antigen delivery. Int J Biol Macromol. 2016;91:716–723.
   PubMed Web of Science ®Google Scholar
• Moghaddam PH, Ramezani V, Esfandi E, et al. Development of a nano–micro carrier system for sustained pulmonary delivery of clarithromycin. Powder Technol. 2013;239:478–483.
   Web of Science ®Google Scholar
• Vila A, Sánchez A, Janes K, et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm. 2004;57(1):123–131.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhang ZR, Huang Y. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers. Int J Pharm. 2007;336(1):166–173.
   PubMedGoogle Scholar
• Ling Y, Cypowyj S, Aytekin C, et al. Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis. J Exp Med. 2015;212(5):619–631.
   PubMed Web of Science ®Google Scholar
• Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F.
   Google Scholar
• Davoine F, Lacy P. Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol. 2014;5:570.
   PubMed Web of Science ®Google Scholar
• Chen L, Guo S, Wu L, et al. Effects of recombinant IL-17F intranasal inoculation against Streptococcus pneumoniae infection in a murine model. Biotechnol Appl Biochem. 2015;62(3):393–400.
   PubMed Web of Science ®Google Scholar
• Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354(6):610–621.
   PubMed Web of Science ®Google Scholar
• Wen ZS, Xu YL, Zou XT, et al. Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice. Mar Drugs. 2011;9:1038–1055.
   PubMed Web of Science ®Google Scholar
• Shibata Y, Honda I, Justice JP, et al. Th1 adjuvant N-acetyl-d-glucosamine polymer up-regulates Th1 immunity but down-regulates Th2 immunity against a mycobacterial protein (MPB-59) in interleukin-10-knockout and wild-type mice. Infect Immun. 2001;69(10):6123–6130.
   PubMed Web of Science ®Google Scholar
• Fernández-Urrusuno R, Calvo P, Remuñán-López C, et al. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm Res. 1999;16(10):1576–1581.
   PubMed Web of Science ®Google Scholar
• Singh B, Maharjan S, Sindurakar P, et al. Needle-free immunization with chitosan-based systems. Int J Mol Sci. 2018;19(11):3639.
   PubMed Web of Science ®Google Scholar
• Casettari L, Illum L. Chitosan in nasal delivery systems for therapeutic drugs. J Control Release. 2014;190:189–200.
   PubMed Web of Science ®Google Scholar